Article
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.
Nature communications - 19 Jan 2024
Shumliakivska Mariana, Luxán Guillermo, Hemmerling Inga, Scheller Marina, Li Xue, Müller-Tidow Carsten, Schuhmacher Bianca, Sun Zhengwu, Dendorfer Andreas, Debes Alisa, Glaser Simone-Franziska, Muhly-Reinholz Marion, Kirschbaum Klara, Hoffmann Jedrzej, Nagel Eike, Puntmann Valentina O, Cremer Sebastian, Leuschner Florian, Abplanalp Wesley Tyler, John David, Zeiher Andreas M, Dimmeler Stefanie
Abstract excerpt
Hematopoietic mutations in epigenetic regulators like DNA methyltransferase 3 alpha (DNMT3A), play a pivotal role in driving clonal hematopoiesis of indeterminate potential (CHIP), and are associated with unfavorable outcomes in patients suffering from heart failure (HF). However, the precise interactions between CHIP-mutated cells and other cardiac cell types remain unknown. Here, we identify fibroblasts as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
